of Cdc42 leads to a loss of the normal asymmetric local-
, Cdc42 has no effect on the affinity of the Par-6 CRIB-PDZ fragment for Pals1. This result Pals1 in COS7 cells, it is not clear if this regulation occurs at the level of the Par-6 PDZ domain.
was verified using fluorescence anisotropy in which Pals1 was found to have an equilibrium dissociation constant of 8 Ϯ 2 M in the absence and 6 Ϯ 2 M in Results the presence of Cdc42 (data not shown). The lack of regulation with these purified components indicates that Identification of Cdc42-Dependent and -Independent Par-6 PDZ Interactions Cdc42 must influence the Par-6/Pals1 interaction indirectly. Par-6 is composed of three protein interaction domains ( Figure 1A) . Two of these domains, the CRIB motif and While Par-3 and Pals1 are internal (i.e., not carboxyterminal) ligands and Cdc42 does not regulate their bindthe PDZ domain, are structurally coupled, and this cou- constitutive manner. The Par-6 PDZ differs in this respect, with low intrinsic affinity for ligand that can be To test this hypothesis, we determined the crystal structure of the PDZ-C-terminal peptide complex. Addiincreased into the low micromolar range upon Cdc42 binding. This may be a common regulatory mechanism tion of high concentrations of VKESLV peptide allowed for formation of PDZ-peptide crystals. These crystals used by protein interaction domains. However, as ligand screens are often performed with isolated domains, lidiffracted to 2.2 Å , and phases were determined using molecular replacement with the PDZ domain from gands regulated in this manner are likely to be missed. As with the Par-6 PDZ domain, ligand binding may only Cdc42-bound Par-6 as a search model (Table 1 ). The bound peptide was readily apparent in the initial electron be observed with the proper set of intra-and/or intermolecular ligands. density maps and the structure was refined to final R factor of 22% and free R of 26% ( Figure 6B resulting in a final model with an R of 22% and R free of 26%. Par-6 and Pals1 were cloned from a mouse macrophage cDNA library. For the Par-6 CRIB-PDZ fragment, Drosophila residues 130-255 were used, whereas residues 156-255 were used for the PDZ NMR Spectroscopy NMR experiments were carried out on a Bruker DRX600 spectromealone.
All proteins were expressed using the E. coli strain BL21(DE3) as ter equipped with a triple-resonance z axis gradient CryoProbe. All NMR samples contained 0.5-1.0 mM 15 N-or 15 N/ 13 C-labeled Par-6 a host strain with pGEX 4T-1-based vectors for GST fusions and pBH-based vectors for hexahistidine fusions. The pBH vector conprotein and were prepared in 90% H 2 O/10% D 2 O containing 20 mM sodium phosphate (pH 5.5), 50 mM sodium chloride, and 0.05% tains the coding sequence for a TEV (tobacco etch virus) protease site following the hexahistidine sequence for removal of the tag. sodium azide. NMR samples of Par-6 complexes with Cdc42 and ligand peptides were obtained by titration of 15 N-labeled Par-6 proHexahistidine fusions were purified using Ni-NTA resin followed by incubation with TEV protease to remove the histidine tag. Tag tein with unlabeled binding partners. Resonance assignments and distance constraints for free Par-6 were derived from the following cleavage was followed by further purification using ion exchange chromatography to achieve a final purity of Ͼ99% as measured by 
